169 related articles for article (PubMed ID: 28197825)
1. Peculiarities in thermal evolution of precipitated amorphous calcium phosphates with an initial Ca/P ratio of 1:1.
Zyman Z; Epple M; Goncharenko A; Rokhmistrov D; Prymak O; Loza K
J Mater Sci Mater Med; 2017 Mar; 28(3):52. PubMed ID: 28197825
[TBL] [Abstract][Full Text] [Related]
2. Phase transformations during processing and in vitro degradation of porous calcium polyphosphates.
Hu Y; Pilliar R; Grynpas M; Kandel R; Werner-Zwanziger U; Filiaggi M
J Mater Sci Mater Med; 2016 Jul; 27(7):117. PubMed ID: 27255688
[TBL] [Abstract][Full Text] [Related]
3. Crystallized nano-sized alpha-tricalcium phosphate from amorphous calcium phosphate: microstructure, cementation and cell response.
Vecbiskena L; Gross KA; Riekstina U; Yang TC
Biomed Mater; 2015 Apr; 10(2):025009. PubMed ID: 25886478
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of novel biphasic calcium phosphate powders (alpha-TCP/HA) derived from carbonated amorphous calcium phosphates.
Li Y; Kong F; Weng W
J Biomed Mater Res B Appl Biomater; 2009 May; 89(2):508-517. PubMed ID: 18937266
[TBL] [Abstract][Full Text] [Related]
5. Correlating crystallinity and reactivity in an alpha-tricalcium phosphate.
Camiré CL; Gbureck U; Hirsiger W; Bohner M
Biomaterials; 2005 Jun; 26(16):2787-94. PubMed ID: 15603774
[TBL] [Abstract][Full Text] [Related]
6. Crystallization behavior of silica-calcium phosphate biocomposites: XRD and FTIR studies.
Ning CQ; Greish Y; El-Ghannam A
J Mater Sci Mater Med; 2004 Nov; 15(11):1227-35. PubMed ID: 15880933
[TBL] [Abstract][Full Text] [Related]
7. An improvement in sintering property of beta-tricalcium phosphate by addition of calcium pyrophosphate.
Ryu HS; Youn HJ; Hong KS; Chang BS; Lee CK; Chung SS
Biomaterials; 2002 Feb; 23(3):909-14. PubMed ID: 11771710
[TBL] [Abstract][Full Text] [Related]
8. Novel highly biodegradable biphasic tricalcium phosphates composed of alpha-tricalcium phosphate and beta-tricalcium phosphate.
Li Y; Weng W; Tam KC
Acta Biomater; 2007 Mar; 3(2):251-4. PubMed ID: 16979393
[TBL] [Abstract][Full Text] [Related]
9. In vitro synthesis and characterization of amorphous calcium phosphates with various Ca/P atomic ratios.
Li Y; Weng W
J Mater Sci Mater Med; 2007 Dec; 18(12):2303-8. PubMed ID: 17562135
[TBL] [Abstract][Full Text] [Related]
10. Calorimetry investigations of milled α-tricalcium phosphate (α-TCP) powders to determine the formation enthalpies of α-TCP and X-ray amorphous tricalcium phosphate.
Hurle K; Neubauer J; Bohner M; Doebelin N; Goetz-Neunhoeffer F
Acta Biomater; 2015 Sep; 23():338-346. PubMed ID: 26026302
[TBL] [Abstract][Full Text] [Related]
11. Phase development and sintering behaviour of biphasic HA-TCP calcium phosphate materials prepared from hydroxyapatite and bioactive glass.
Behnamghader A; Bagheri N; Raissi B; Moztarzadeh F
J Mater Sci Mater Med; 2008 Jan; 19(1):197-201. PubMed ID: 17597356
[TBL] [Abstract][Full Text] [Related]
12. Calcium phosphate apatites with variable Ca/P atomic ratio I. Synthesis, characterisation and thermal stability of powders.
Raynaud S; Champion E; Bernache-Assollant D; Thomas P
Biomaterials; 2002 Feb; 23(4):1065-72. PubMed ID: 11791909
[TBL] [Abstract][Full Text] [Related]
13. Effect of PEG amount in amorphous calcium phosphate on its crystallized products.
Liu S; Weng W; Li Z; Pan L; Cheng K; Song C; Du P; Shen G; Han G
J Mater Sci Mater Med; 2009 Jan; 20(1):359-63. PubMed ID: 18807264
[TBL] [Abstract][Full Text] [Related]
14. α-Tricalcium phosphate: synthesis, properties and biomedical applications.
Carrodeguas RG; De Aza S
Acta Biomater; 2011 Oct; 7(10):3536-46. PubMed ID: 21712105
[TBL] [Abstract][Full Text] [Related]
15. Effect of Mg(2+) doping on beta-alpha phase transition in tricalcium phosphate (TCP) bioceramics.
Frasnelli M; Sglavo VM
Acta Biomater; 2016 Mar; 33():283-9. PubMed ID: 26796207
[TBL] [Abstract][Full Text] [Related]
16. Alpha-tricalcium phosphate (α-TCP): solid state synthesis from different calcium precursors and the hydraulic reactivity.
Cicek G; Aksoy EA; Durucan C; Hasirci N
J Mater Sci Mater Med; 2011 Apr; 22(4):809-17. PubMed ID: 21445656
[TBL] [Abstract][Full Text] [Related]
17. Remineralization of enamel subsurface lesions by casein phosphopeptide-stabilized calcium phosphate solutions.
Reynolds EC
J Dent Res; 1997 Sep; 76(9):1587-95. PubMed ID: 9294493
[TBL] [Abstract][Full Text] [Related]
18. Preparation of tricalcium phosphate/calcium pyrophosphate structures via rapid prototyping.
Gbureck U; Hölzel T; Biermann I; Barralet JE; Grover LM
J Mater Sci Mater Med; 2008 Apr; 19(4):1559-63. PubMed ID: 18236137
[TBL] [Abstract][Full Text] [Related]
19. Influence of magnesium doping on the phase transformation temperature of beta-TCP ceramics examined by Rietveld refinement.
Enderle R; Götz-Neunhoeffer F; Göbbels M; Müller FA; Greil P
Biomaterials; 2005 Jun; 26(17):3379-84. PubMed ID: 15621226
[TBL] [Abstract][Full Text] [Related]
20. Effect of amorphous phases during the hydraulic conversion of α-TCP into calcium-deficient hydroxyapatite.
Hurle K; Neubauer J; Bohner M; Doebelin N; Goetz-Neunhoeffer F
Acta Biomater; 2014 Sep; 10(9):3931-41. PubMed ID: 24681375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
